EUCTR2021-001335-24-DK进行中（未招募）1 期
Thromboprophylaxis in Oesophageal Cancer Patients – A Randomized, Controlled Trial - Thromboprophylaxis in Oespohageal Cancer Patients
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Cancer located in the oesophagus and/or cardia
- •2.Candidate for intended curative surgery.
- •3.Age > 18 years.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •1.Known inherited bleeding disorder.
- •2.Unable to provide informed consent.
- •3.Arterial or venous thromboembolic events within the last three months.
- •4.On-going anticoagulant treatment (Vitamin K antagonists or direct oral anticoagulants).
- •5.Pregnant or has given birth within the last three months.
- •6.Known allergy to the trial drug Dalteparin (Fragmin®).
研究者
相似试验
Unknown
4 期
Thromboprophylaxis in Oesophageal Cancer PatientsEsophageal NeoplasmsThrombosisThromboembolismNCT05067153University of Aarhus100
已完成
不适用
Study of treatment for esophageal cancerEsophageal cancerJPRN-UMIN000040909Graduate School of Medical Sciences,Kyushu University26
已完成
2 期
Phase II Feasibility Study of Gold Fiducial Markers forSurgical-Pathological Localisation and Chemotherapy ResponseAssessment in the Multi-Disciplinary Team Management ofOesophageal-Gastric CancerOesophageal - gastric cancerCancer - Oesophageal (gullet)Cancer - StomachACTRN12613000387729Austin Health20
招募中
不适用
Thromboprophylaxis in patients with moderate COVID-19COVID-19JPRN-UMIN000046519Port said University124
进行中（未招募）
1 期
PLAnning Treatment For Oesophago-Gastric Cancer: a Randomised Maintenance Therapy TrialOesophago-gastric adenocarcinomaEUCTR2014-002169-30-GBThe Royal Marsden NHS Foundation Trust770